From October 1, 2021 to December 31, 2021, the company has repurchased 22,603 shares, representing 0.15% for KRW 731.46 million. With this, the company has completed the repurchase of 29,720 shares, representing 0.2% for KRW 1,124.9 million under the buyback announced on December 10, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,170 KRW | +0.06% | -1.55% | +0.41% |
1st Jan change | Capi. | |
---|---|---|
+0.41% | 186M | |
+21.40% | 44.15B | |
+23.03% | 23.02B | |
+19.25% | 15.33B | |
+12.80% | 13.74B | |
+48.72% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.66B |
- Stock Market
- Equities
- A271980 Stock
- News Jeil Pharmaceutical Co.,Ltd
- Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on December 10, 2020.